By understanding the science and business of health care, our experienced team invests in companies addressing unmet medical needs or those that seek to make the health care system more efficient.
Watch the investment team recap this quarter.
(Note: Filmed in July 2024).
| Asset class | Equities |
| Product Structure | OEIC |
| Inception Date | Sep 14, 2023 |
| Base Currency | GBP |
|
Fund Assets As of 30/06/24 |
$29.73M |
| Index | MSCI World Health Care Index |
| Index Usage | Target |
| Peer Group Benchmark | IA Healthcare |
| Peer Group Benchmark Usage | Comparator |
| Year End | 31-Oct |
| Pricing Basis | Single Priced |
Portfolio Manager | Research Analyst
Industry since 2000. Joined Firm in 2000.
Our intellectual capital is readily available and central to our Knowledge Shared approach"
Low valuations and accelerating innovation are helping biotech recover from one of its worst drawdowns on record.
Janus Henderson’s recent Global Investment Summit explored growth drivers in equities, noting record levels of innovation in healthcare and technology as well as developments in real estate and sustainability.
Artificial intelligence is only beginning to make inroads into the healthcare sector. Here’s how investors might benefit today.
